Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-Dose Efavirenz Combo in Virally Suppressed HIV Patients
NCT03595709Phase 3Completed
- Start
- Dec 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of efavirenz in human immunodeficiency virus infection (HIV). Started Dec 2018; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03595709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03595709.